Partners for Progress in Breast Cancer Research and Care
In November 2016 I did the IMPACT* Advocacy training program at the annual Clinical Oncology Society of Australia (COSA) conference. Over three days I learnt about the latest research from around the globe on breast cancer and current treatments (surgical and chemotherapeutic).
I’m going to post some slides, and summaries on the latest chemotherapy drug combinations to target HER2 positive breast cancer. If you have the HER2 gene mutation this could be useful.
(I’m the one in the red-desert pattern dress.)
*Improving Participation and Advocacy for Clinical Trials.